Clinical Impact of New Viral Hepatitis Data From AASLD 2022*

Download All
November 4-8, 2022; Washington, DC
Get up to date on the latest practice-changing viral hepatitis data presented at AASLD 2022. Review key studies on HBV, HCV, and HDV; view on-demand webcasts; listen to the on-demand podcasts; download the slides; and read expert commentaries.
Nancy Reau, MD
Stefan Zeuzem, MD

On-Demand Webcasts

Listen to expert insights on updates and new viral hepatitis data from AASLD 2022, including data on HBV therapy during pregnancy, HBV therapeutic vaccines and progress toward HBV cure, HDV clinical impact and phase III clinical trial updates, and HCV implementation science and HCC risk reduction with use of DAAs.

Stefan Zeuzem, MD Released: December 7, 2022

Listen to expert insights on updates and new viral hepatitis data from AASLD 2022, including data on HBV therapy during pregnancy, HBV therapeutic vaccines and progress toward HBV cure, HDV clinical impact and phase III clinical trial updates, and HCV implementation science and HCC risk reduction with use of DAAs.

Nancy Reau, MD Released: December 8, 2022
Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie Inc.
Gilead Sciences, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings